UNSPSC 51142511: Entacapone

This classification denotes an antiparkinsonian agent with the molecular formula C14H15N3O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4975G9NM6T, chemically known as 2-propenamide, 2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)-n,n-diethyl- but generally known as entacapone, which bears US NIH Compound Identifier 5281081. European Medicines Agency schedules Entacapone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06552MIG.

UNSPSC 51142511 Entacapone is a Commodity code for a specific pharmaceutical product, but the recent state and local procurement activity tagged under this code does not involve entacapone itself. Seminole County, Florida posted IFB 60459723LAS in June 2026 seeking naloxone and safe drug deactivation systems — products outside the nominal scope of this code. The mismatch suggests either a tagging error in the state procurement record or a broader pharmaceutical-procurement classification that has drifted from the code's intended use. State and local agencies appear to use this code infrequently or incorrectly for specific drug procurements.

The single recent opportunity on file is Seminole County's IFB for naloxone and drug deactivation systems, with a response deadline of July 26, 2023, and a two-year initial term plus one-year renewal option. The county requires quarterly deliveries of 1,900 units of naloxone and 800 deactivation systems annually to its Community Health Building in Sanford, with vendors absorbing shipping costs. Bidders must comply with drug-free workplace certification, E-Verify requirements, and federal regulations including the Clean Air Act if FEMA funding applies. The procurement offers no explicit set-aside designations. Given the single opportunity and the code-to-solicitation mismatch, this code shows little meaningful recent activity in state and local procurement.